Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Spray vs Budesonide Irrigation in CRSwNP
NCT03323866Phase 3Terminated
- Sponsor
- Université de Sherbrooke
- Start
- May 2017
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of EPI-EE in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Université de Sherbrooke. Started May 2017; status: terminated.
02
Drugs
EPI-EE
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT03323866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03323866.